0001209191-24-003293.txt : 20240213
0001209191-24-003293.hdr.sgml : 20240213
20240213205658
ACCESSION NUMBER: 0001209191-24-003293
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240210
FILED AS OF DATE: 20240213
DATE AS OF CHANGE: 20240213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Novack David F
CENTRAL INDEX KEY: 0001573072
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34207
FILM NUMBER: 24631511
MAIL ADDRESS:
STREET 1: 39 YORKSHIRE DR
CITY: OAKLAND
STATE: CA
ZIP: 94618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0001029142
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 330728374
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 POWELL STREET
STREET 2: SUITE 720
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 5108485100
MAIL ADDRESS:
STREET 1: 2100 POWELL STREET
STREET 2: SUITE 720
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-02-10
0
0001029142
DYNAVAX TECHNOLOGIES CORP
DVAX
0001573072
Novack David F
C/O DYNAVAX TECHNOLOGIES
2100 POWELL STREET, SUITE 720
EMERYVILLE
CA
94608
0
1
0
0
President & COO
0
Common Stock
2024-02-10
4
M
0
8833
A
24034
D
Common Stock
2024-02-12
4
F
0
3151
12.82
D
20883
D
Restricted Stock Unit
2024-02-10
4
M
0
8833
D
Common Stock
8833
8833
D
Code M: Exercise or conversion of derivative security
Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022.
Code F: Payment of exercise price or tax liability by delivering or withholding securities
Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.
/s/ DAVID NOVACK
2024-02-13